Hybio Pharmaceutical Co., Ltd. (SZSE:300199) announces a share repurchase program. Under the program the company will repurchase for not more than CNY 800 million worth of its shares. The shares will be purchased at a price not exceeding CNY 16 per share. The plan is valid for 12 months.